{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:41:06Z","timestamp":1791218466724,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS077946"],"award-info":[{"award-number":["R01NS077946"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000433"],"award-info":[{"award-number":["UL1TR000433"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["R01NS040068"],"award-info":[{"award-number":["R01NS040068"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH, Center for Inherited Disease Research"},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s11136-019-02391-7","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T09:04:31Z","timestamp":1576659871000},"page":"1393-1403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Psychometric properties and responsiveness of Neuro-QoL Cognitive Function in persons with Huntington disease (HD)"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0439-9429","authenticated-orcid":false,"given":"Noelle E.","family":"Carlozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane S.","family":"Paulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy R.","family":"Downing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Ready","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel S.","family":"Perlmutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin L.","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Shei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,18]]},"reference":[{"issue":"1","key":"2391_CR1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/mds.25717","volume":"29","author":"ER Fisher","year":"2014","unstructured":"Fisher, E. R., & Hayden, M. R. (2014). Multisource ascertainment of Huntington disease in Canada: Prevalence and population at risk. Movement Disorders,29(1), 105\u2013114.","journal-title":"Movement Disorders"},{"issue":"9","key":"2391_CR2","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","volume":"27","author":"T Pringsheim","year":"2012","unstructured":"Pringsheim, T., et al. (2012). The incidence and prevalence of Huntington\u2019s disease: A systematic review and meta-analysis. Movement Disorders,27(9), 1083\u20131091.","journal-title":"Movement Disorders"},{"key":"2391_CR3","volume-title":"Neurobiology of Huntington\u2019s disease: Applications to drug discovery frontiers in neuroscience","author":"HL Paulson","year":"2011","unstructured":"Paulson, H. L., & Albin, R. L. (2011). Huntington\u2019s disease: Clinical features and routes to therapy. In D. C. Lo & R. E. Hughes (Eds.), Neurobiology of Huntington\u2019s disease: Applications to drug discovery frontiers in neuroscience. Boca Raton: CRC Press."},{"issue":"6","key":"2391_CR4","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/WNL.0b013e3181eccfa2","volume":"75","author":"K Duff","year":"2010","unstructured":"Duff, K., et al. (2010). Mild cognitive impairment in prediagnosed Huntington disease. Neurology,75(6), 500\u2013507.","journal-title":"Neurology"},{"issue":"8","key":"2391_CR5","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","volume":"79","author":"JS Paulsen","year":"2008","unstructured":"Paulsen, J. S., et al. (2008). Detection of Huntington\u2019s disease decades before diagnosis: The predict-HD study. Journal of Neurology, Neurosurgery and Psychiatry,79(8), 874\u2013880.","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"9","key":"2391_CR6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/mds.22953","volume":"25","author":"GM Peavy","year":"2010","unstructured":"Peavy, G. M., et al. (2010). Cognitive and functional decline in Huntington\u2019s disease: Dementia criteria revisited. Movement Disorders,25(9), 1163\u20131169.","journal-title":"Movement Disorders"},{"issue":"3","key":"2391_CR7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11136-017-1755-6","volume":"27","author":"JS Lai","year":"2018","unstructured":"Lai, J. S., et al. (2018). Evaluating cognition in individuals with Huntington disease: Neuro-QoL cognitive functioning measures. Quality of Life Research,27(3), 811\u2013822.","journal-title":"Quality of Life Research"},{"key":"2391_CR8","first-page":"RRN1250","volume":"3","author":"AL Vaccarino","year":"2011","unstructured":"Vaccarino, A. L., et al. (2011). Assessment of cognitive symptoms in prodromal and early Huntington disease. PLoS Currents,3, RRN1250.","journal-title":"PLoS Currents"},{"issue":"2","key":"2391_CR9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/1359105312438109","volume":"18","author":"NE Carlozzi","year":"2013","unstructured":"Carlozzi, N. E., & Tulsky, D. S. (2013). Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. Journal of Health Psychology,18(2), 212\u2013225.","journal-title":"Journal of Health Psychology"},{"key":"2391_CR10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/h0054651","volume":"18","author":"J Stroop","year":"1935","unstructured":"Stroop, J. (1935). Studies of interference in serial verbal reactions. Journal of Experimental Psychology,18, 643\u2013662.","journal-title":"Journal of Experimental Psychology"},{"key":"2391_CR11","volume-title":"Symbol digit modalities test: Manual","author":"A Smith","year":"1982","unstructured":"Smith, A. (1982). Symbol digit modalities test: Manual. Western Psychological Services: Los Angeles."},{"issue":"1","key":"2391_CR12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/00207458409079534","volume":"24","author":"E Koss","year":"1984","unstructured":"Koss, E., et al. (1984). The Stroop color-word test: Indicator of dementia severity. International Journal of Neuroscience,24(1), 53\u201361.","journal-title":"International Journal of Neuroscience"},{"key":"2391_CR13","volume-title":"Contributions to neuropsychological assessment","author":"AL Benton","year":"1994","unstructured":"Benton, A. L., et al. (1994). Contributions to neuropsychological assessment (2nd ed.). New York: Oxford University Press.","edition":"2"},{"issue":"3","key":"2391_CR14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3233\/JHD-140115","volume":"3","author":"NE Carlozzi","year":"2014","unstructured":"Carlozzi, N. E., et al. (2014). Understanding the outcomes measures used in Huntington disease pharmacological trials: A systematic review. Journal of Huntington\u2019s Disease,3(3), 233\u2013252.","journal-title":"Journal of Huntington\u2019s Disease"},{"issue":"2","key":"2391_CR15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1037\/neu0000102","volume":"29","author":"JK Williams","year":"2015","unstructured":"Williams, J. K., et al. (2015). Everyday cognition in prodromal Huntington disease. Neuropsychology,29(2), 255\u2013267.","journal-title":"Neuropsychology"},{"issue":"9","key":"2391_CR16","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1080\/13803395.2013.833178","volume":"35","author":"NE Carlozzi","year":"2013","unstructured":"Carlozzi, N. E., Grech, J., & Tulsky, D. S. (2013). Memory functioning in individuals with traumatic brain injury: An examination of the Wechsler Memory Scale-Fourth Edition (WMS-IV). Journal of Clinical and Experimental Neuropsychology,35(9), 906\u2013914.","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"issue":"4","key":"2391_CR17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1099-1166(199904)14:4<291::AID-GPS902>3.0.CO;2-7","volume":"14","author":"C Derouesne","year":"1999","unstructured":"Derouesne, C., et al. (1999). Memory complaints in young and elderly subjects. International Journal of Geriatric Psychiatry,14(4), 291\u2013301.","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"8","key":"2391_CR18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/00019442-200508000-00013","volume":"13","author":"NT Lautenschlager","year":"2005","unstructured":"Lautenschlager, N. T., et al. (2005). Subjective memory complaints with and without objective memory impairment: Relationship with risk factors for dementia. The American Journal of Geriatric Psychiatry,13(8), 731\u2013734.","journal-title":"The American Journal of Geriatric Psychiatry"},{"issue":"9","key":"2391_CR19","first-page":"1155","volume":"111","author":"N Mostafaie","year":"2004","unstructured":"Mostafaie, N., et al. (2004). Mitochondrial genotype and risk for Alzheimer\u2019s disease: Cross-sectional data from the Vienna-Transdanube-Aging \u201cVITA\u201d study. Journal of Neural Transmission (Vienna),111(9), 1155\u20131165.","journal-title":"Journal of Neural Transmission (Vienna)"},{"issue":"7","key":"2391_CR20","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1212\/WNL.53.7.1511","volume":"53","author":"SM Sawrie","year":"1999","unstructured":"Sawrie, S. M., et al. (1999). Subjective versus objective memory change after temporal lobe epilepsy surgery. Neurology,53(7), 1511\u20131517.","journal-title":"Neurology"},{"issue":"3","key":"2391_CR21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2466\/pms.2001.93.3.761","volume":"93","author":"IW Schmidt","year":"2001","unstructured":"Schmidt, I. W., Berg, I. J., & Deelman, B. G. (2001). Relations between subjective evaluations of memory and objective memory performance. Perceptual and Motor Skills,93(3), 761\u2013776.","journal-title":"Perceptual and Motor Skills"},{"issue":"2","key":"2391_CR22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1037\/0882-7974.11.2.272","volume":"11","author":"GE Smith","year":"1996","unstructured":"Smith, G. E., et al. (1996). Subjective memory complaints, psychological distress, and longitudinal change in objective memory performance. Psychology and Aging,11(2), 272\u2013279.","journal-title":"Psychology and Aging"},{"issue":"6","key":"2391_CR23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/153331750401900610","volume":"19","author":"T Zandi","year":"2004","unstructured":"Zandi, T. (2004). Relationship between subjective memory complaints, objective memory performance, and depression among older adults. American Journal of Alzheimer\u2019s Disease and Other Dementias,19(6), 353\u2013360.","journal-title":"American Journal of Alzheimer\u2019s Disease and Other Dementias"},{"issue":"Suppl 1","key":"2391_CR24","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.apmr.2011.01.025","volume":"92","author":"D Cella","year":"2011","unstructured":"Cella, D., et al. (2011). The neurology quality of life measurement (Neuro-QOL) initiative. Archives of Physical Medicine and Rehabilitation,92(Suppl 1), S28\u2013S36.","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"3","key":"2391_CR25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11136-011-9958-8","volume":"21","author":"RC Gershon","year":"2012","unstructured":"Gershon, R. C., et al. (2012). Neuro-QOL: Quality of life item banks for adults with neurological disorders: Item development and calibrations based upon clinical and general population testing. Quality of Life Research,21(3), 475\u2013486.","journal-title":"Quality of Life Research"},{"issue":"10","key":"2391_CR26","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s11136-016-1386-3","volume":"25","author":"NE Carlozzi","year":"2016","unstructured":"Carlozzi, N. E., et al. (2016). HDQLIFE: Development and assessment of health-related quality of life in Huntington disease (HD). Quality of Life Research,25(10), 2441\u20132455.","journal-title":"Quality of Life Research"},{"key":"2391_CR27","unstructured":"Novack, T. (2000). The Orientation Log. The Center for Outcome Measurement in Brain Injury."},{"issue":"3","key":"2391_CR28","first-page":"304","volume":"11","author":"RC Gershon","year":"2010","unstructured":"Gershon, R. C., et al. (2010). The use of PROMIS and assessment center to deliver patient-reported outcome measures in clinical research. Journal of Applied Measurement,11(3), 304\u2013314.","journal-title":"Journal of Applied Measurement"},{"issue":"2","key":"2391_CR29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"Huntington Study Group","year":"1996","unstructured":"Huntington Study Group. (1996). Unified Huntington\u2019s Disease Rating Scale: Reliability and consistency. Huntington Study Group. Movement Disorders,11(2), 136\u2013142.","journal-title":"Movement Disorders"},{"key":"2391_CR30","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.31.10.1333","volume":"31","author":"I Shoulson","year":"1981","unstructured":"Shoulson, I. (1981). Huntington disease: Functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology,31, 1333\u20131335.","journal-title":"Neurology"},{"issue":"2","key":"2391_CR31","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1212\/WNL.54.2.452","volume":"54","author":"K Marder","year":"2000","unstructured":"Marder, K., et al. (2000). Rate of functional decline in Huntington\u2019s disease. Neurology,54(2), 452.","journal-title":"Neurology"},{"key":"2391_CR32","unstructured":"SAS Institute. (2013). SAS 9.4 language reference concepts. Cary, NC: SAS Institute."},{"key":"2391_CR33","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1969","unstructured":"Cohen, J. (1969). Statistical power analysis for the behavioral sciences. New York: Academic Press."},{"key":"2391_CR34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ip.2.2.135","volume":"2","author":"B Kopjar","year":"1996","unstructured":"Kopjar, B. (1996). The SF-36 health survey: A valid measure of changes in health status after injury. Injury Prevention,2, 135\u2013139.","journal-title":"Injury Prevention"},{"key":"2391_CR35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0149-2918(02)85118-9","volume":"24","author":"K Dineen","year":"2002","unstructured":"Dineen, K., et al. (2002). Meaningful change in cancer-specific quality-of-life scores: Differences between improvement and worsening. Clinical Therapeutics,24, 41\u201342.","journal-title":"Clinical Therapeutics"},{"issue":"1","key":"2391_CR36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","volume":"60","author":"CB Terwee","year":"2007","unstructured":"Terwee, C. B., et al. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology,60(1), 34\u201342.","journal-title":"Journal of Clinical Epidemiology"},{"key":"2391_CR37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yebeh.2013.11.008","volume":"31","author":"D Victorson","year":"2014","unstructured":"Victorson, D., et al. (2014). Validity of the Neurology Quality-of-Life (Neuro-QoL) measurement system in adult epilepsy. Epilepsy Behavior,31, 77\u201384.","journal-title":"Epilepsy Behavior"},{"issue":"1","key":"2391_CR38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.dhjo.2017.04.008","volume":"11","author":"D Amtmann","year":"2018","unstructured":"Amtmann, D., et al. (2018). People with multiple sclerosis report significantly worse symptoms and health related quality of life than the US general population as measured by PROMIS and NeuroQoL outcome measures. Disability and Health Journal,11(1), 99\u2013107.","journal-title":"Disability and Health Journal"},{"issue":"4","key":"2391_CR39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.apmr.2015.12.010","volume":"97","author":"AJ Kozlowski","year":"2016","unstructured":"Kozlowski, A. J., et al. (2016). Evaluating individual change with the quality of life in neurological disorders (Neuro-QoL) short forms. Archives of Physical Medicine and Rehabilitation,97(4), 650\u2013654.","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"3","key":"2391_CR40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1179\/jmt.2009.17.3.163","volume":"17","author":"SJ Kamper","year":"2009","unstructured":"Kamper, S. J., Maher, C. G., & Mackay, G. (2009). Global rating of change scales: A review of strengths and weaknesses and considerations for design. Journal of Manual and Manipulative Therapy,17(3), 163\u2013170.","journal-title":"Journal of Manual and Manipulative Therapy"},{"issue":"4","key":"2391_CR41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/13607860600638487","volume":"10","author":"S Cook","year":"2006","unstructured":"Cook, S., & Marsiske, M. (2006). Subjective memory beliefs and cognitive performance in normal and mildly impaired older adults. Aging & Mental Health,10(4), 413\u2013423.","journal-title":"Aging & Mental Health"},{"issue":"12","key":"2391_CR42","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/j.0013-9580.2004.54503.x","volume":"45","author":"TT Lineweaver","year":"2004","unstructured":"Lineweaver, T. T., et al. (2004). Patients\u2019 perceptions of memory functioning before and after surgical intervention to treat medically refractory epilepsy. Epilepsia,45(12), 1604\u20131612.","journal-title":"Epilepsia"},{"issue":"2","key":"2391_CR43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1532-5415.2004.52066.x","volume":"52","author":"S Jungwirth","year":"2004","unstructured":"Jungwirth, S., et al. (2004). Subjective memory complaints and objective memory impairment in the Vienna-Transdanube aging community. Journal of the American Geriatrics Society,52(2), 263\u2013268.","journal-title":"Journal of the American Geriatrics Society"},{"issue":"6","key":"2391_CR44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1176\/appi.psy.44.6.461","volume":"44","author":"LJ Podewils","year":"2003","unstructured":"Podewils, L. J., et al. (2003). Relationship of self-perceptions of memory and worry to objective measures of memory and cognition in the general population. Psychosomatics,44(6), 461\u2013470.","journal-title":"Psychosomatics"},{"issue":"2","key":"2391_CR45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3200\/GNTP.167.2.221-240","volume":"167","author":"CM Reese","year":"2006","unstructured":"Reese, C. M., & Cherry, K. E. (2006). Effects of age and ability on self-reported memory functioning and knowledge of memory aging. Journal of Genetic Psychology,167(2), 221\u2013240.","journal-title":"Journal of Genetic Psychology"},{"issue":"7","key":"2391_CR46","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ctrv.2012.05.002","volume":"38","author":"AD Hutchinson","year":"2012","unstructured":"Hutchinson, A. D., et al. (2012). Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews,38(7), 926\u2013934.","journal-title":"Cancer Treatment Reviews"},{"key":"2391_CR47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5334\/tohm.231","volume":"4","author":"E McCusker","year":"2014","unstructured":"McCusker, E., & Loy, C. T. (2014). The many facets of unawareness in huntington disease. Tremor and Other Hyperkinetic Movements (N Y),4, 257.","journal-title":"Tremor and Other Hyperkinetic Movements (N Y)"},{"issue":"4","key":"2391_CR48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/arclin\/11.4.295","volume":"11","author":"AW Deckel","year":"1996","unstructured":"Deckel, A. W., & Morrison, D. (1996). Evidence of a neurologically based \u201cdenial of illness\u201d in patients with Huntington\u2019s disease. Archives of Clinical Neuropsychology,11(4), 295\u2013302.","journal-title":"Archives of Clinical Neuropsychology"},{"issue":"1","key":"2391_CR49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s100720170066","volume":"22","author":"C Vitale","year":"2001","unstructured":"Vitale, C., et al. (2001). Unawareness of dyskinesias in Parkinson\u2019s and Huntington\u2019s diseases. Neurological Sciences,22(1), 105\u2013106.","journal-title":"Neurological Sciences"},{"issue":"3","key":"2391_CR50","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1176\/jnp.17.3.378","volume":"17","author":"A Chatterjee","year":"2005","unstructured":"Chatterjee, A., et al. (2005). A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington\u2019s disease. Journal of Neuropsychiatry and Clinical Neurosciences,17(3), 378\u2013383.","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"2","key":"2391_CR51","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1176\/jnp.2010.22.2.196","volume":"22","author":"K Duff","year":"2010","unstructured":"Duff, K., et al. (2010). \u201cFrontal\u201d behaviors before the diagnosis of Huntington\u2019s disease and their relationship to markers of disease progression: Evidence of early lack of awareness. Journal of Neuropsychiatry and Clinical Neurosciences,22(2), 196\u2013207.","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"10","key":"2391_CR52","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s11136-018-1912-6","volume":"27","author":"NE Carlozzi","year":"2018","unstructured":"Carlozzi, N. E., et al. (2018). Understanding patient-reported outcome measures in Huntington disease: At what point is cognitive impairment related to poor measurement reliability? Quality of Life Research,27(10), 2541\u20132555.","journal-title":"Quality of Life Research"},{"issue":"1","key":"2391_CR53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen, J. (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement,20(1), 10.","journal-title":"Educational and Psychological Measurement"},{"key":"2391_CR54","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2014.03.010","volume":"259","author":"KM Smith","year":"2014","unstructured":"Smith, K. M., & Dahodwala, N. (2014). Sex differences in Parkinson\u2019s disease and other movement disorders. Experimental Neurology,259, 44\u201356.","journal-title":"Experimental Neurology"},{"issue":"9","key":"2391_CR55","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi, S. J., et al. (2009). Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. Lancet Neurology,8(9), 791\u2013801.","journal-title":"Lancet Neurology"},{"key":"2391_CR56","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnagi.2014.00078","volume":"6","author":"JS Paulsen","year":"2014","unstructured":"Paulsen, J. S., et al. (2014). Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: A decade of the PREDICT-HD study. Frontiers in Aging Neuroscience,6, 78.","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"11","key":"2391_CR57","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/aje\/kwh141","volume":"159","author":"KM Dunn","year":"2004","unstructured":"Dunn, K. M., et al. (2004). Patterns of consent in epidemiologic research: Evidence from over 25,000 responders. American Journal of Epidemiology,159(11), 1087\u20131094.","journal-title":"American Journal of Epidemiology"},{"issue":"1","key":"2391_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/074823379701300101","volume":"13","author":"JA Burg","year":"1997","unstructured":"Burg, J. A., Allred, S. L., & Sapp, J. H., 2nd. (1997). The potential for bias due to attrition in the National Exposure Registry: An examination of reasons for nonresponse, nonrespondent characteristics, and the response rate. Toxicology and Industrial Health,13(1), 1\u201313.","journal-title":"Toxicology and Industrial Health"},{"issue":"8","key":"2391_CR59","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0895-4356(02)00431-6","volume":"55","author":"TM Eagan","year":"2002","unstructured":"Eagan, T. M., et al. (2002). Nonresponse in a community cohort study: Predictors and consequences for exposure-disease associations. Journal of Clinical Epidemiology,55(8), 775\u2013781.","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"2391_CR60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/01.GIM.0000132688.55591.77","volume":"6","author":"JS Roberts","year":"2004","unstructured":"Roberts, J. S., et al. (2004). Who seeks genetic susceptibility testing for Alzheimer\u2019s disease? Findings from a multisite, randomized clinical trial. Genetics in Medicine,6(4), 197\u2013203.","journal-title":"Genetics in Medicine"},{"issue":"1","key":"2391_CR61","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/jamaneurol.2015.2736","volume":"73","author":"PI Huntington Study Group","year":"2016","unstructured":"Huntington Study Group, P. I., et al. (2016). Clinical-genetic associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for clinical trials. JAMA Neurology,73(1), 102\u2013110.","journal-title":"JAMA Neurology"},{"issue":"6","key":"2391_CR62","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archneur.63.6.883","volume":"63","author":"JS Paulsen","year":"2006","unstructured":"Paulsen, J. S., et al. (2006). Preparing for preventive clinical trials: The predict-HD study. Archives of Neurology,63(6), 883\u2013890.","journal-title":"Archives of Neurology"},{"key":"2391_CR63","volume-title":"Huntington\u2019s disease: A disorder of families","author":"SE Folstein","year":"1989","unstructured":"Folstein, S. E. (1989). Huntington\u2019s disease: A disorder of families. Baltimore: Johns Hopkins University Press."},{"key":"2391_CR64","first-page":"193","volume":"58","author":"MR Hayden","year":"1980","unstructured":"Hayden, M. R., MacGregor, J. M., & Beighton, P. H. (1980). The prevalence of Huntington\u2019s chorea in South Africa. South African Medical Journal,58, 193\u2013196.","journal-title":"South African Medical Journal"},{"key":"2391_CR65","first-page":"253","volume":"1","author":"H Narabayashi","year":"1973","unstructured":"Narabayashi, H. (1973). Huntington\u2019s chorea in Japan: Review of the literature. Advances in Neurology,1, 253\u2013259.","journal-title":"Advances in Neurology"},{"issue":"7","key":"2391_CR66","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/ajmg.b.31232","volume":"156B","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y., et al. (2011). Indexing disease progression at study entry with individuals at-risk for Huntington disease. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics,156B(7), 751\u2013763.","journal-title":"American Journal of Medical Genetics Part B-Neuropsychiatric Genetics"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-019-02391-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11136-019-02391-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-019-02391-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:52:05Z","timestamp":1608166325000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11136-019-02391-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,18]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["2391"],"URL":"https:\/\/doi.org\/10.1007\/s11136-019-02391-7","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,18]]},"assertion":[{"value":"9 December 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. University of Michigan Medical School Institutional Review Board, HUM00055669, initial approval 2\/1\/2012. Cleveland Clinic Institutional Review Board, IRB# 13-460, initial approval 4\/26\/2013. Indiana University Institutional Review Board (IRB-01), Protocol # 1208009383, initial approval 9\/7\/2012. Johns Hopkins Medicine Institutional Review Board, Study # NA_00079341, initial approval 12\/13\/2012. University of Medicine & Dentistry of New Jersey (which was subsumed by Rutgers University) Institutional Review Board, Study ID Pro2012002196, initial approval 4\/4\/2013. Park Nicollet Institute Institutional Review Board, Study 04334-13-A, initial approval 11\/15\/2013. University of California San Francisco Institutional Review Board, IRB # 13-10880 Reference # 065701, initial approval 9\/4\/2013. University of California Los Angeles Institutional Review Board, IRB # 12-000743, initial approval 6\/12\/2012. University of Iowa Institutional Review Board, IRB ID # 201301724, initial approval 1\/17\/2013. Washington University in St. Louis Institutional Review Board, IRB ID # 201206052, initial approval 8\/14\/2012. Northwestern University Institutional Review Board deemed this study (STU00200337) was determined exempt (\u201cNot Human Research Determination\u201d) on 2\/9\/2015.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}